Search
  • mmahomed2

Phase II SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases

Valitor has been awarded a Phase II SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This project will enable us to refine an IND-candidate for our lead compound, as well as to identify additional related applications for our multivalent protein conjugation technology.

0 views

© Valitor, Inc 2020

  • LinkedIn - White Circle